GlassScriptPhysician profile
Jamie Flynn
NPI 1013391911
$567.94
in general payments reported to CMS, 2019-2025
15 companies · $150 in 2025
The $150 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $84.40 · 2023: $41.62 · 2024: $292 · 2025: $150.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $484.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $483.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $113.15 | 2023-2025 | Cologuard Collection Kit |
| Novo Nordisk INC | $68.58 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Lilly USA, LLC | $55.56 | 2024 | Mounjaro, Zepbound |
| Pfizer INC. | $53.81 | 2024-2025 | |
| Glaxosmithkline, LLC. | $44.75 | 2019-2024 | Arexvy, Shingrix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $36.56 | 2024 | Jardiance |
| Acera Surgical, INC. | $34.24 | 2025 | Restrata Wound Matrix |
| Pulmonx Corporation | $33.85 | 2024 | Chartis Catheter, Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console |
| Astrazeneca Pharmaceuticals LP | $31.18 | 2019-2025 | Airsupra |
| Merck Sharp & Dohme LLC | $25.40 | 2019 | |
| Bausch Health US, LLC | $17.07 | 2025 | Wellbutrin |
| Ars Pharmaceuticals Operations, INC. | $17.00 | 2025 | Neffy |
| Pacira Pharmaceuticals Incorporated | $13.69 | 2024 | Iovera, Exparel, Zilretta |
| Dynavax Technologies Corporation | $11.56 | 2023 | Heplisav-B |
| Genentech USA, INC. | $11.54 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jamie Flynn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.